The Single Cell Analysis Program (SCAP) has transitioned from Common Fund support. Common Fund programs are strategic investments that achieve a set of high-impact goals within a 5-10 year timeframe. At the conclusion of each program, deliverables will transition to other sources of support or use within the scientific community. SCAP was supported by the Common Fund from 2012 to 2017. SCAP's major accomplishments include new and unique tools, which are enabling researchers to carry out experiments that were not previously possible. Examples include transcriptome in vivo analysis (TIVA) tag for RNA capture, inDrop for high throughput single cell transcriptomics, fluorescent in situ sequencing, whole genome nuclear sequencing and the dual-view inverted selective plane illumination microscope (diSPIM) imaging system, which provides tracking of cell lineage in living, multicellular organisms - to name a few. TSCAP has also significantly moved the field of single molecule fluorescent in situ hybridization for RNA and protein detection forward, including the detection of single nucleotide variants, multiplexing the detection of tens of RNAs and proteins and RNA detection into live cells using CRISPR. A further consequence of SCAP is the establishment of the SCAP-Transcriptome Consortium project, which developed a public portal with phenotypic information and next generation sequencing data of whole transcriptome for 697 single cells from 56 subjects. The SCAP-T Consortium has also established procedures for depositing meta-data and RNAseq data to the NIH National Center for Biotechnology Information (NCBI) database of Genotypes and-Phenotype (dbGaP).
Please note that since the SCAP program is no longer supported by the Common Fund, the program website is being maintained as an archive and will not be updated on a regular basis.
The Single Cell Analysis Program supported centers examining the transcriptional signatures of individual human cells in order to measure and analyze cellular heterogeneity and to define specific cell types and/or cell “states” in a given population; individual research studies that focus on the discovery and early development of exceptionally innovative tools for early stage, high-risk/high-impact projects to enable and improve single cell analysis; and individual research studies that accelerate the integration and translation of technologies to characterize single cells (see the Funded Research for specific research project).
Read more about the Program Goals and Initiatives.
This page last reviewed on August 1, 2018